Cargando…

Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)

Detalles Bibliográficos
Autores principales: Rodriguez, JM, Delgado, M, Viciana, P, Lopez-Ruz, MA, Leal, M, Alcacer, F, Deig, E, Antela, A, Pedrol, E, Moreno, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113085/
http://dx.doi.org/10.1186/1758-2652-13-S4-P79
_version_ 1782205884503425024
author Rodriguez, JM
Delgado, M
Viciana, P
Lopez-Ruz, MA
Leal, M
Alcacer, F
Deig, E
Antela, A
Pedrol, E
Moreno, S
author_facet Rodriguez, JM
Delgado, M
Viciana, P
Lopez-Ruz, MA
Leal, M
Alcacer, F
Deig, E
Antela, A
Pedrol, E
Moreno, S
author_sort Rodriguez, JM
collection PubMed
description
format Online
Article
Text
id pubmed-3113085
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130852011-06-13 Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study) Rodriguez, JM Delgado, M Viciana, P Lopez-Ruz, MA Leal, M Alcacer, F Deig, E Antela, A Pedrol, E Moreno, S J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113085/ http://dx.doi.org/10.1186/1758-2652-13-S4-P79 Text en Copyright ©2010 Rodriguez et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Rodriguez, JM
Delgado, M
Viciana, P
Lopez-Ruz, MA
Leal, M
Alcacer, F
Deig, E
Antela, A
Pedrol, E
Moreno, S
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
title Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
title_full Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
title_fullStr Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
title_full_unstemmed Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
title_short Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
title_sort switching to nevirapine (nvp) significantly increases high-density lipoprotein cholesterol (hdl-c) in treatment-experienced patients (nevicor study)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113085/
http://dx.doi.org/10.1186/1758-2652-13-S4-P79
work_keys_str_mv AT rodriguezjm switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT delgadom switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT vicianap switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT lopezruzma switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT lealm switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT alcacerf switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT deige switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT antelaa switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT pedrole switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy
AT morenos switchingtonevirapinenvpsignificantlyincreaseshighdensitylipoproteincholesterolhdlcintreatmentexperiencedpatientsnevicorstudy